首页> 外文会议>Falk Liver Week >Primary sclerosing cholangitis: indications for and recurrence after transplantation
【24h】

Primary sclerosing cholangitis: indications for and recurrence after transplantation

机译:原发性硬化性胆管炎:移植后的适应症和复发

获取原文

摘要

Medical management of primary sclerosing cholangitis (PSC) has been disappointing. Immunosuppressive drugs, copper-chelating agents, and antibiotics do not appear to alter progression of the disease Treatment with ursodeoxycholic acid may slow progression of disease. The judicious use of dilation of strictures can palliate jaundice and may improve survival, but liver transplantation remains the definitive treatment.
机译:原发性硬化胆管炎(PSC)的医学管理一直令人失望。免疫抑制药物,铜螯合剂和抗生素似乎没有改变核糖胆酸的疾病治疗的进展可能会减缓疾病的进展。狭窄的明智使用可以缓解黄疸,可以改善存活,但肝移植仍然是最终的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号